---
created: '2026-02-13T17:49:24.501559Z'
description: Encodes the p300 protein, a histone acetyltransferase that regulates
  transcription via chromatin remodeling. Mutations cause Rubinstein-Taybi syndrome.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/gene/ep300/
slug: ep300
tags:
- gene
- epigenetic_regulator
- histone_modification
- imported
- primekg
templateEngineOverride: njk
title: EP300
type: gene
updated: '2026-02-13T17:49:24.501559Z'
---

{% raw %}
<h1>EP300</h1>
<h2>Overview</h2>
<p>The <strong>EP300</strong> gene encodes the <strong>p300</strong> protein, a transcriptional co-activator and Histone Acetyltransferase (HAT). It functions as a crucial epigenetic regulator, modifying chromatin structure to allow for gene expression.</p>
<p>p300 works in close association with <strong>CBP (CREB-binding protein)</strong>, and they are often referred to collectively as the p300/CBP family. Together, they regulate cell growth, differentiation, and DNA repair by acetylating histones and non-histone proteins (like p53).</p>
<h2>Biological Functions</h2>
<h3>1. Histone Acetylation</h3>
<p>p300 adds acetyl groups to lysine residues on histone tails (H3, H4). This neutralizes the positive charge of histones, loosening the DNA-histone interaction and making chromatin accessible to transcription factors (open chromatin or euchromatin).</p>
<h3>2. Transcriptional Co-activation</h3>
<p>It acts as a bridge (scaffold) connecting DNA-bound transcription factors (like CREB, p53, HIF-1alpha) to the basal transcription machinery, facilitating gene expression.</p>
<h2>Clinical Significance</h2>
<ul>
<li><strong>Rubinstein-Taybi Syndrome (RSTS):</strong> Heterozygous germline mutations in EP300 cause RSTS Type 2 (Type 1 is caused by CREBBP). Features include intellectual disability, broad thumbs/toes, and craniofacial abnormalities.</li>
<li><strong>Cancer:</strong> p300 can act as both a tumor suppressor and an oncogene depending on the context. Somatic mutations are found in various epithelial cancers.</li>
<li><strong>Viral Interaction:</strong> The protein was originally identified by its binding to the E1A oncoprotein of Adenovirus, which inhibits p300 function to drive viral replication.</li>
</ul>
<h2>Relationships</h2>
<p>ENCODES::<a class="internal-link is-unresolved" href="/404">p300 Protein</a><br />
REGULATES::<a class="internal-link is-unresolved" href="/404">Gene Expression</a> - Via histone acetylation<br />
REGULATES::<a class="internal-link is-unresolved" href="/404">Cell Cycle</a><br />
INTERACTS_WITH::<a href="/garden/dev_admin/protein/crebbp/" class="internal-link">CREBBP</a> - Functional paralog<br />
INTERACTS_WITH::<a href="/garden/dev_admin/protein/tp53/" class="internal-link">TP53</a> - Acetylates p53 to increase stability<br />
INTERACTS_WITH::<a class="internal-link is-unresolved" href="/404">HIF-1alpha</a> - Regulates hypoxia response<br />
ASSOCIATED_WITH_CONDITION::<a class="internal-link is-unresolved" href="/404">Rubinstein-Taybi Syndrome</a> - Germline mutation<br />
ASSOCIATED_WITH_CONDITION::<a href="/garden/dev_admin/condition/cancer/" class="internal-link">Cancer</a> - Somatic mutation<br />
MODIFIES::<a class="internal-link is-unresolved" href="/404">Histones</a> - Acetylation</p>
<h2>References</h2>
<ul>
<li>Goodman, R. H., &amp; Smolik, S. (2000). CBP/p300 in cell growth, transformation, and development. Genes &amp; Development, 14(13), 1553-1577.</li>
<li>Roelfsema, J. H., et al. (2005). Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes. American Journal of Human Genetics, 76(4), 572-580.</li>
</ul>

{% endraw %}